Learn about our expanded patient care options for your health care needs.
General Information | Self-Checker | Donate and Lend Support | Staff Appreciation | Get Email Alerts
Enter the last name, specialty or keyword for your search below.
Spring/Summer 2014
Bizarre visions and fantastic reveries are surprisingly common among ICU patients—and far from benign. A Hopkins team is pushing to prevent “the stuff that dreams are made of.”
Dramatic advances in immunotherapy offer new options for patients with advanced melanoma.
Chetan Bettegowda is hot on the high-tech trail of DNA fragments that could point to more effective treatments for brain cancer.
How three “big data” projects at Johns Hopkins have the potential to transform the future health of a toddler today.
A boost in minority medical student enrollment, toying with cancer, high-impact council, bedside manners(s), a new venture in Saudi Arabia, and more.
Often misdiagnosed as dementia, adult hydrocephalus can be reversed, notes Daniele Rigamonti. Plus: Coping with bipolar disorder and a spotlight on aging eyes.
When CRT doesn’t work, the straight poop on preventing liver failure in infants, toward better Zzzzs, successful snare, radiation watchdogs, and more.
With life-saving chemotherapy drugs in short supply, the time for collaborative solutions is now.
The 110 fourth-year medical students in Hopkins’ Class of 2014—together with family members, mentors, and friends—gathered at Hopkins’ Armstrong Building on March 21 for the rite of passage known as Match Day. A noontime countdown, followed by the collective ripping of envelopes, quickly dissolved into hugs, tears of joy, champagne toasts, and cross-country phone calls for those assembled, as they celebrated news of their destinations for the next three to seven years of residency training. Notably, a third of the class (some 36 graduates) will train at hospitals that are part of the Johns Hopkins Medicine system.
View a video of Match Day 2014.
Studying epithelial cells (red), which give rise to 85 percent of all cancers, Johns Hopkins researchers turned on a gene called Twist1, with dramatic results. Within 24 hours, dozens of individual cells (green) began to migrate past the epithelial boundary and into the gel beyond. This and other findings from the lab of Andrew Ewald, assistant professor of cell biology and oncology, could help clarify the molecular changes required for cancer cells to metastasize.
You can choose to support a specific cause at Johns Hopkins about which you are passionate, or you can make a contribution that will support our priorities in research, patient care and medical education.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
